Erratum: cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum

YeLing Ruan; TianYi Chen; LongBo Zheng; JingWei Cai; Hu Zhao; YaLi Wang; LiYe Tao; JunJie Xu; Lin Ji; XiuJun Cai

doi:10.7150/ijbs.113876

Erratum: cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum

Int J Biol Sci. 2025 Jun 16;21(9):4129-4130. doi: 10.7150/ijbs.113876. eCollection 2025.

Authors

YeLing Ruan^{1

2}, TianYi Chen^{1

2}, LongBo Zheng³, JingWei Cai^{1

2}, Hu Zhao^{1

2}, YaLi Wang^{1

2}, LiYe Tao^{1

2}, JunJie Xu^{1

2

4

5}, Lin Ji^{1

2}, XiuJun Cai^{1

2

4

5}

Affiliations

¹ Key Laboratory of Laparoscopic Technology of Zhejiang Province, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine - Hangzhou, China.
² Zhejiang Minimal Invasive Diagnosis and Treatment Technology Research Center of Severe Hepatobiliary Disease, Zhejiang Research and Development Engineering Laboratory of Minimally Invasive Technology and Equipment - Hangzhou, China.
³ Department of Gastroenterology, The Affiliated Hospital of Qingdao University - Qingdao, China.
⁴ Zhejiang University Cancer Center - Hangzhou, China.
⁵ Liangzhu Laboratory, Zhejiang University Medical Center - Hangzhou, China.

Abstract

[This corrects the article DOI: 10.7150/ijbs.86227.].

Publication types

Published Erratum